landiolol (Pending FDA Approval)

Brand and Other Names:
  • Print

Dosing & Uses

Supraventricular Tachycardia

Pending FDA approval for treatment of supraventricular tachycardia, including atrial fibrillation and atrial flutter

Next:

Pharmacology

Mechanism of Action

Ultra-short acting, cardioselective, beta1 blocker that results in decreased heart rate

Previous
Next:

Images

No images available for this drug.
Previous
Next:

Patient Handout

A Patient Handout is not currently available for this monograph.
Previous
Medscape prescription drug monographs are based on FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature.